Last updated on November 2017

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort, as an Active Control, on Lung Function in Subjects with Moderate to Severe COPD


Brief description of study

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort, as an Active Control, on Lung Function in Subjects with Moderate to Severe COPD

Detailed Study Description

This is a 6-month treatment study for patients with moderate to very severe COPD.

Clinical Study Identifier: TX15212

Contact Investigators or Research Sites near you

Start Over

Lisa Hendrich, RN

Alpine Clinical Research Center
Boulder, CO USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.